Hubei Province Pharma Moves

29 May 1997

The China Daily Business Weekly has reported a number of importantdevelopments in China's Hubei province. The city of Wuxue is to establish a major pharmaceuticals production base, with three large and 20 small production companies, and 3 billion renminbi ($360.6 million) of annual output value.

Also, Huanggang is to establish a new wholesale market for the trading of pharmaceuticals. Some locally-produced drugs could be exported to Hong Kong via the new Beijing-Kowloon railway.

Finally, the Huangjinqiao Economic, Science and Technology Development Zone in Macheng is seeking foreign investment for the construction of export-oriented pharmaceutical and medicinal materials in the zone. Foreign investors could benefit from preferential taxes and other financial incentives.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight